Sun Pharma Advanced Research Company informs about outcome of board meeting

29 Jan 2018 Evaluate

Sun Pharma Advanced Research Company has informed that the Board of Directors of the Company at their meeting held from 12:00 Noon to 02:00 pm today, took on record and duly approved the Un-audited financial results of the Company for the quarter and nine months ended 31st December 2017 which is enclosed herewith along with the Limited Review Report of the Statutory Auditors thereon as Annexure I.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

134.45 0.70 (0.52%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 643.75
Indegene 519.25
CMS Info Systems 339.55
Sagility 52.19
Smartworks Coworking 476.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×